SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
DaVita Inc. (DVA) trades at a trailing P/E of 17.2, forward P/E of 10.5. Trailing earnings yield is 5.80%, forward earnings yield 9.49%. PEG 0.22 (Peter Lynch undervalued ≤1.0). Graham Number is $51.24.
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (17.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.22); analyst target implies upside (+12.9%); earnings yield beats bond yields (5.80%).
- Forward P/E 10.5 (down from trailing 17.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.80% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 9.49% as earnings recover.
- Analyst consensus target $168.67 (+12.9% upside) — modest upside expected.
Overall SharesGrow Score: 59/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DVA
Valuation Multiples
P/E (TTM)17.2
Forward P/E10.5
PEG Ratio0.22
Forward PEG0.22
P/B Ratio-19.76
P/S Ratio0.73
EV/EBITDA9.2
Per Share Data
EPS (TTM)$8.67
Forward EPS (Est.)$14.17
Book Value / Share$13.45
Revenue / Share$158.46
FCF / Share$15.22
Yields & Fair Value
Earnings Yield5.80%
Forward Earnings Yield9.49%
Dividend Yield0.00%
Graham Number$51.24
SharesGrow IV$360.50 (+141.2%)
Analyst Target$168.67 (+12.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
14.7 |
0.06 |
2.79 |
0.88 |
- |
| 2017 |
20.5 |
-1.07 |
2.91 |
1.25 |
- |
| 2018 |
55.1 |
1.75 |
2.37 |
0.77 |
- |
| 2019 |
14.2 |
0.99 |
5.39 |
1.01 |
- |
| 2020 |
18.2 |
0.77 |
10.17 |
1.22 |
- |
| 2021 |
12.2 |
0.29 |
15.84 |
1.03 |
- |
| 2022 |
12.4 |
-0.34 |
9.75 |
0.60 |
- |
| 2023 |
13.8 |
0.46 |
9.01 |
0.78 |
- |
| 2024 |
13.6 |
0.30 |
104.94 |
0.99 |
- |
| 2025 |
13.1 |
-1.11 |
-15.02 |
0.72 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.29 |
$14.75B |
$879.87M |
6% |
| 2017 |
$3.47 |
$10.88B |
$663.62M |
6.1% |
| 2018 |
$4.58 |
$11.4B |
$790.08M |
6.9% |
| 2019 |
$5.27 |
$11.39B |
$810.98M |
7.1% |
| 2020 |
$6.39 |
$11.55B |
$773.64M |
6.7% |
| 2021 |
$8.90 |
$11.62B |
$978.45M |
8.4% |
| 2022 |
$8.02 |
$11.61B |
$768.19M |
6.6% |
| 2023 |
$7.42 |
$12.14B |
$691.54M |
5.7% |
| 2024 |
$10.73 |
$12.82B |
$936.34M |
7.3% |
| 2025 |
$9.51 |
$13.64B |
$746.8M |
5.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$14.13 |
$13.81 – $14.30 |
$13.99B |
$13.78B – $14.27B |
4 |
| 2027 |
$16.27 |
$16.21 – $16.34 |
$14.4B |
$14.15B – $14.8B |
4 |
| 2028 |
$18.29 |
$17.93 – $18.94 |
$14.81B |
$14.64B – $14.98B |
1 |
| 2029 |
$18.12 |
$17.77 – $18.76 |
$15.89B |
$15.66B – $16.33B |
1 |
